Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Genzyme Corporation    GENZ

GENZYME CORPORATION

(GENZ)
 SummaryNewsCompany 
Company
More about the company
Latest news on GENZYME CORPORATION
2011GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society..
PU
2011GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to Interna..
BU
2011GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launchin..
BU
2011GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease..
BU
2011GENZYME CORP.GNL : Genzyme Reports Financial Results for Fourth Quarter of 2010 ..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Diagnostics Business to Sekisui Che..
BU
2011GENZYME CORP.GNL : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
BU
2011GENZYME CORP.GNL : Genzyme to Build Additional Plant to Support Growth of Myozym..
BU
2011GENZYME CORP.GNL : Genzyme Financial Recovery Continues in Fourth Quarter
BU
2011GENZYME CORP.GNL : Genzyme Statement on Discussions With Sanofi-Aventis
BU
2010GENZYME CORP.GNL : Genzyme Details Market Potential of Alemtuzumab for MS
BU
2010GENZYME CORP.GNL : Genzyme to Hold Investor Event on Alemtuzumab
BU
2010GENZYME CORP.GNL : Genzyme Reiterates Board's Position on Sanofi-Aventis Tender ..
BU
2010GENZYME CORP.GNL : Genzyme Completes Sale of Genetic Testing Business to LabCorp
BU
More news
News in other languages on GENZYME CORPORATION
2011GENZYME : succès de l'OPE de Sanofi-aventis.
2011GENZYME : Sanofi-aventis modifie son offre.
2011GENZYME CORP.GNL : Résultat trimestriel de Genzyme dans la fourchette annoncée
2011GENZYME : racheté par Sanofi-Aventis.
2011GENZYME CORP.GNL : bénéfice inférieur aux attentes
More news
Sector news : Bio Therapeutic Drugs
01/14Freeport Rules Out Deals in Near Term -- WSJ
DJ
01/13Freeport-McMoran Isn't Looking for Strategic Deals in Coming Years, CEO Says
DJ
01/13Novartis to speed access to $10 billion heart drug via NHS deal
RE
01/13Drugmakers Test New Ways to Pay for Six-Figure Treatments
DJ
01/08In a vigorous defense, Carlos Ghosn claims he has done nothing wrong
More sector news : Bio Therapeutic Drugs
Sector and Competitors
1st jan.Capitalization (M$)
GENZYME CORPORATION0
GILEAD SCIENCES-3.08%79 679
VERTEX PHARMACEUTICALS7.71%60 644
REGENERON PHARMACEUTICALS2.69%42 192
WUXI APPTEC CO., LTD.5.22%23 217
GENMAB2.36%14 684